
Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections - EU-Startups
Telum Therapeutics is focused on developing innovative treatments for hospital-acquired infections. The company aims to address critical healthcare challenges with its advanced therapeutic solutions. This funding round will help accelerate their research and development efforts.
Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections EU-Startups
| Jun 22, 2026 | Grid.online | $4.3M | — | Ireland |
| Jun 18, 2026 | Cargofy | $10.2M | — | Ireland |
| Jun 10, 2026 | Trustap | $10.0M | Series A | Ireland |
| Jun 10, 2026 | CameraMatics | $52.0M | — | Ireland |